ICON Public Limited Company ( ICLR) - Key Metrics
ICLR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $26.85 | $0.94 | $3.61 | $3.06 |
| 2026Q1 | $26.56 | $1.37 | $2.18 | $1.78 |
| 2025Q4 | $26.94 | $1.90 | $9.79 | $7.94 |
| 2025Q3 | $26.40 | $0.03 | $5.28 | $4.55 |
| 2025Q2 | $25.46 | $2.31 | $2.05 | $1.61 |
ICLR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 46.20 |
| 2026Q1 | 0% | 20.19 |
| 2025Q4 | 0% | 23.36 |
| 2025Q3 | 0% | 1439.14 |
| 2025Q2 | 0% | 15.74 |
ICLR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.76% | 0% |
| 2026Q1 | 1.61% | 0% |
| 2025Q4 | 4.36% | 0% |
| 2025Q3 | 2.60% | 0% |
| 2025Q2 | 1.11% | 0% |
ICLR
Price: $164.85
52 week price:
Earnings Per Share: 0.65 USD
P/E Ratio: 241.31
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: Ireland
Volume: 457160
Ebitda: 105.9 millionMarket Capitalization: 12.3 billion